REVB Director Lakhmir S. Chawla Receives 32,011-Share Award

What Happened Lakhmir S. Chawla, a director of Revelation Biosciences, received a grant of 32,011 restricted shares on 2026-08-17. The award was reported at $0.00 per share (no cash paid) and is recorded as an award/grant (transaction code A) on the Form 4.

Key Details

• Transaction date: 2026-08-17; Form 4 filed: 2026-08-18 (filed within the standard 2-business-day window).
• Shares granted: 32,011; reported acquisition price: $0.00 (value shown as $0 on the filing).
• Shares owned after transaction: Not disclosed in the filing.
• Award plan: Granted under the Revelation Biosciences, Inc. 2021 Equity Incentive Plan (per footnote).
• Vesting: 50% vests on the two-year anniversary of the grant, remaining 50% vests on the four-year anniversary, subject to continued service; vesting may accelerate upon achievement of certain performance milestones.
• No tax withholding, sale, or 10b5-1 plan noted in the filing.

Context This was a restricted stock grant, not an open-market purchase or sale. Because the shares are subject to multi-year vesting (and potential performance conditions), they are not immediately liquid and do not necessarily reflect immediate buying or selling activity by the director. Grants like this are a common part of executive/director compensation and should be viewed in that context.